The association between NAT2 genotype-inferred acetylation status and risk of bladder cancer stratified by hepatic N-acetylation status determined by caffeine metabolic ratio (CMR), The Shanghai Bladder Cancer Study. This evidence concerns the gene NAT2 and urinary bladder cancer.